RxDoctor Payments Data

Sercan Yalcin, MD

Sports Medicine · Cleveland, OHNPI 1699345678

Payments from drug & device makers

What this record shows

This record is dominated by grants: $25,625 of the $36,739 with a category attached, or 69.7%. 13 manufacturers reported payments, led by Arthrex at 59.9% of the total. Reporting peaked in 2024 at $33,897 and has fallen 91.9% since, to $2,738 in 2025. Among sports medicine clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$36,739in general payments, 2019–2025

Across 79 payments — averaging $465.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$22K
  • Smith+Nephew$6K
  • Medical Device Business Services, Inc.$4K
  • Zimmer Biomet$1K
  • Anika Therapeutics, Inc.$1K
  • Stryker$987
  • plus $2K from 7 others

What the payments were for

  • Grants$25,62570%
  • Travel & lodging$8,17822%
  • Food & beverage$2,9368%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,739 in reported general payments places this provider in the 90th percentile of 278 sports medicine providers in Ohio.

See all sports medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$8,210
Medicare patients
64
Services billed
158

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam49$203

Paid to pharmacies, not to this prescriber.

Other sports medicine in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →